In California, researchers at University of California San Diego School of Medicine and Shiley Eye Institute at UC San Diego Health, with colleagues in China, used the gene-editing tool, CRISPR, to reprogram mutated rod photoreceptors and restoring vision in two mouse models. Retinitis pigmentosa is an inherited vision disorder resulting from genetic mutation in more than 60 genes making it difficult for night vision, peripheral vision, color discernment and central vision. It affects about 1 in 4,000 people globally with the eventual result possibly becoming legal blindness and there is no current treatment for it. The ability of researchers to shut off or deactivate certain gene “switches” allowed them to modify select genes to restore vision. They hope to perform clinical trials on humans soon since there is no other treatment or cure for retinitis pigmentosa currently.
Latest article
LSU prof Naohiro Kato creates okra seed Mardi Gras beads
In New Orleans, Louisiana State University Associate Professor Naohiro Kato has created an updated version of his biobased Mardis Gras beads that contain okra...
Amazon, IIT Roorkee trial mailers made from India’s ag waste
In India, e-commerce giant Amazon has partnered with the Indian Institute of Technology Roorkee in a 15-month pilot project to convert agricultural waste into...
Sony creates materials consortium to find bioplastics suitable for electronics
In Tokyo, Sony Corporation is leading a large consortium of materials manufacturers to create a supply chain for biobased plastics that can be used...